56 articles for D Kim
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
15
Identification and characterization of potent, selective and metabolically stable IKKß inhibitor.

The Catholic University of Korea
7
Discovery of 2-aryloxy-4-amino-quinazoline derivatives as novel protease-activated receptor 2 (PAR2) antagonists.

Yonsei University
24
Discovery and optimization of adamantane carboxylic acid derivatives as potent diacylglycerol acyltransferase 1 inhibitors for the potential treatment of obesity and diabetes.

Korea Research Institute of Chemical Technology
19
Discovery of novel pyrimidine and malonamide derivatives as TGR5 agonists.

Chung-Ang University
24
Discovery of potent and selective dipeptidyl peptidase IV inhibitors derived from beta-aminoamides bearing subsituted triazolopiperazines.

Merck Research Laboratories
7
Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation.

Chonnam National University
9
Inhibition and structural reliability of prenylated flavones from the stem bark of Morus lhou on β-secretase (BACE-1).

Gyeongsang National University
4
Structure-based virtual screening approach to the discovery of phosphoinositide 3-kinase alpha inhibitors.

Sejong University
42
2-Arylbenzoxazoles as CETP inhibitors: raising HDL-C in cynoCETP transgenic mice.

Merck Research Laboratories
14
Arylpiperazine-containing pyrimidine 4-carboxamide derivatives targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressant.

Green Cross
10
Evaluation of heterocyclic acid equivalents as tetrazole replacements in imidazopyridine-based nonpeptide angiotensin II receptor antagonists

TBA
22
Acidic phenols: a new class of potent nonpeptide angiotensin II receptor antagonists

TBA
21
Imidazo[4,5-b]pyridine-based AT
1 / AT
2 angiotensin II receptor antagonists

TBA
28
Discovery of thiophen-2-ylmethylene bis-dimedone derivatives as novel WRN inhibitors for treating cancers with microsatellite instability.

Korea University
33
Structural Modification and Biological Evaluation of 2,8-Disubstituted Adenine and Its Nucleosides as A2A Adenosine Receptor Antagonists: Exploring the Roles of Ribose at Adenosine Receptors.

Seoul National University
17
Design, synthesis, and biological evaluation of triazolopiperazine-based beta-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors.

Merck Research Laboratories
37
Identification and Biological Evaluation of a Potent and Selective JAK1 Inhibitor for the Treatment of Pulmonary Fibrosis.

Ewha Womans University
33
Triazolopiperazine-amides as dipeptidyl peptidase IV inhibitors: close analogs of JANUVIA (sitagliptin phosphate).

Merck Research Laboratories
42
2-Amino-1,3,4-thiadiazoles as Glutaminyl Cyclases Inhibitors Increase Phagocytosis through Modification of CD47-SIRPα Checkpoint.

Ewha Womans University
12
Drug-like Inhibitors of DC-SIGN Based on a Quinolone Scaffold.

Max Planck Institute of Colloids and Interfaces
29
Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic properties.

Merck Research Laboratories
1
Discovery of a 2,4-diphenyl-5,6-dihydrobenzo(h)quinolin-8-amine derivative as a novel DNA intercalating topoisomerase IIα poison.

Yeungnam University
18
Discovery of G Protein-Biased Ligands against 5-HT

Korea Institute of Science and Technology
1
Optimization and Evaluation of Novel Antifungal Agents for the Treatment of Fungal Infection.

Korea Institute of Science & Technology (Kist)
22
Discovery of G Protein-Biased Antagonists against 5-HT

Korea Institute of Science and Technology
31
Design and Synthesis of TRAP1 Selective Inhibitors: H-Bonding with Asn171 Residue in TRAP1 Increases Paralog Selectivity.

Ewha Womans University
9
Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists.

Chung-Ang University
2
The food-grade antimicrobial xanthorrhizol targets the enoyl-ACP reductase (FabI) in Escherichia coli.

Yonsei University
19
Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infection.

Merck Research Laboratories
16
Discovery of human CCR5 antagonists containing hydantoins for the treatment of HIV-1 infection.

Merck Research Laboratories
10
Design, Synthesis, and Biological Evaluation of New Peripheral 5HT

Gwangju Institute of Science and Technology
32
Discovery of 2-((4-resorcinolyl)-5-aryl-1,2,3-triazol-1-yl)acetates as potent Hsp90 inhibitors with selectivity over TRAP1.

Daegu-Gyeongbuk Medical Innovation Foundation (Dgmif)
50
Potent, orally absorbed glucagon receptor antagonists.

Merck Research Laboratories
1
Glechomanamides A-C, Germacrane Sesquiterpenoids with an Unusual Δ

Seoul National University
12
Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava.

Korea Research Institute of Bioscience and Biotechnology
16
Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition.

Korea Research Institute of Bioscience and Biotechnology
3
Synthesis of benzoxazole derivatives as interleukin-6 antagonists.

Ewha Womans University
248
POLQ INHIBITORS

AstraZeneca
81
Heterocyclic compounds as class II phosphoinositide 3-kinase inhibitors

Forschungsverbund Berlin
15
THERAPEUTIC MEDICINE FOR HEART DISEASE OR SKELETAL MUSCLE DISEASE

Shionogi
26
PRMT5 INHIBITING COMPOUNDS AND USES THEREOF

Antengene Discovery
6
Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia

Stealth Biotherapeutics
7
Phenyl-3,4-dihydroisoquinolin-2(1h)-yl-ethan-1-one derivatives as dopamine d1receptor positive allosteric modulators

Eli Lilly
25
TRICYCLIC COMPOUNDS

Recurium Ip Holdings
117
6-aryl-7-substituted-3-(1H-pyrazol-5-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as inhibitors of the STAT3 pathway with anti-proliferative activity

University of Pittsburgh
190
1 H-pyrazolo[4,3-B]pyridines as PDE1 inhibitors

H. Lundbeck
137
Imidazolonylquinolines and the use thereof as ATM kinase inhibitors

Merck Patent
105
1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof

Samumed
28
Transformation of the Non-Selective Aminocyclohexanol-Based Hsp90 Inhibitor into a Grp94-Seletive Scaffold.

The University of Kansas
18
Synthesis, Biological Evaluation, and Molecular Docking of 8-imino-2-oxo-2H,8H-pyrano[2,3-f]chromene Analogs: New Dual AChE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease.

Yogi Vemana University
53
4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of CCR2

Janssen Pharmaceutica
11
In vitro binding characteristics of a new selective group II metabotropic glutamate receptor radioligand, [3H]LY354740, in rat brain.

F. Hoffmann-La Roche
1
Human serotonin 5-HT7 receptor: cloning and pharmacological characterisation of two receptor variants.

Organon
12
Design and campaign synthesis of piperidine- and thiazole-based histone deacetylase inhibitors.

AstraZeneca